Cite

HARVARD Citation

    Snir, A. et al. (n.d.). Anti-IL-6 receptor antibody (tocilizumab): a B cell targeting therapy. Annals of the rheumatic diseases. pp. A57-A58. [Online]. 
  
Back to record